Cetera Investment Advisers
ANIX icon

Cetera Investment Advisers’s Anixa Biosciences ANIX Stock Holding History

Cetera Investment Advisers’s Portfolio ANIX Stock Details ANIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$38.5K Buy
13,750
+2,623
+24% +$7.29K ﹤0.01% 4800
2026
Q1 		$28.7K Hold
11,127
– – ﹤0.01% 4632
2025
Q4 		$34.7K Buy
+11,127
New +$45.6K ﹤0.01% 4544

Other funds holding ANIX

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $5.21B AUM 31.48% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Cetera Investment Advisers's ANIX Position: Q2 2026 in Review

Cetera Investment Advisers increased its Anixa Biosciences (ANIX) stake by 24% in Q2 2026, buying an estimated $7.29K and bringing the position to 13,750 shares worth $38.5K. The position accounts for ﹤0.01% of the portfolio, ranked #4800.

Cetera Investment Advisers first reported a position in ANIX in Q4 2025 and has held it in 3 quarters since. 63 funds tracked by Wall St. Rank hold ANIX as of Q2 2026.

  • Cetera Investment Advisers held 13,750 shares of Anixa Biosciences worth $38.5K as of Q2 2026.
  • Cetera Investment Advisers bought 2,623 Anixa Biosciences shares in Q2 2026, an estimated $7.29K.
  • Anixa Biosciences made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #4800 holding.
  • Cetera Investment Advisers first reported a position in Anixa Biosciences in Q4 2025 and has held it in 3 quarters since.
  • 63 funds tracked by Wall St. Rank held Anixa Biosciences as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.